Announces Funding Round
Announces Funding Round
London, Sep 19, 2012 AEST (ABN Newswire) - Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that it has commenced a 5m Euro (GBP3.9m) funding round to enable it to further expand its acquisition and development programmes.

Jack Kaye, Westhouse Chairman said "this funding round will allow Westhouse to complete on a number of targeted acquisitions and ensure that the company can continue to develop and support its technology to enable it to bring products to market in a timely manner"

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

About Westhouse Medical Services Plc

Westhouse Medical (FRA:5WM) consists of two wholly-owned subsidiaries: Westhouse Medical Ltd and Westhouse Medical Devices Ltd. Westhouse is expanding rapidly through the acquisition and expansion of primary healthcare businesses within Europe and North America". Westhouse Medical Services Plc has a dynamic range of Medical Services and Devices providing cutting edge innovation in the medical sectors such as a non-invasive
Test for Breast Cancer and a patented procedure to treat glaucoma.



Global Press and Public Relations:
Gabriel Luca/Michael Westhaver
Wedgewood Communications
Tel: +1-646-592-7559

Westhouse Medical Services Plc

Related Companies

Westhouse Medical Services Plc    
Wedgewood Investment Group LLC.             

ABN Newswire This Page Viewed:  (Last 7 Days: 2) (Last 30 Days: 24) (Since Published: 4180) 

Social Media